Third HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide for relapsed acute leukemia

Author:

Harada NaonoriORCID,Okamura Hiroshi,Makuuchi YosukeORCID,Kuno MasatomoORCID,Takakuwa Teruhito,Nakamae MikaORCID,Nishimoto Mitsutaka,Nakashima YasuhiroORCID,Koh Hideo,Hino Masayuki,Nakamae HirohisaORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Reference10 articles.

1. Tachibana T, Matsumoto K, Tanaka M, Hagihara M, Motohashi K, Yamamoto W, et al. Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation. Leuk Lymphoma. 2017;58:1403–11. https://doi.org/10.1080/10428194.2016.1243678.

2. Rank A, Peczynski C, Labopin M, Stelljes M, Simand C, Helbig G, et al. Feasibility and outcomes of a third allogeneic hematopoietic stem cell transplantation: a retrospective analysis from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Transplant Cell Ther. 2021;27:408.e401–8.e406. https://doi.org/10.1016/j.jtct.2021.01.025.

3. Kobayashi S, Kanda Y, Konuma T, Inamoto Y, Matsumoto K, Uchida N, et al. Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation. Bone Marrow Transpl. 2022;57:43–50. https://doi.org/10.1038/s41409-021-01485-6.

4. Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med. 1984;3:35–44. https://doi.org/10.1002/sim.4780030106.

5. Christopeit M, Kuss O, Finke J, Bacher U, Beelen DW, Bornhauser M, et al. Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change. J Clin Oncol. 2013;31:3259–71. https://doi.org/10.1200/jco.2012.44.7961.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3